Literature DB >> 14630981

Childhood vaccine development: an overview.

Jeffrey P Baker1, Samuel L Katz.   

Abstract

Vaccines against childhood diseases represent some of the most important applications of 20th-century pediatric research. This survey examines how the components of the current U.S. immunization schedule emerged in three phases during the course of the century. The first phase, after the development of bacterial culture techniques, witnessed numerous efforts in the early 1900s to develop bacterial vaccines. It proved most fruitful with respect to diphtheria, tetanus, and pertussis. The rise of viral tissue culture techniques in the 1950s brought about a second phase of innovation resulting in vaccines against polio, measles, mumps, rubella, and varicella. A third wave of innovation, still very much alive, has drawn on a variety of new technologies and led to vaccines against hepatitis B, Haemophilus influenzae type b, pneumococcus, and still other organisms. Although basic science research has thus been a primary factor shaping the history of vaccine development, the collaboration between the academic, private, and public sectors critical to its application has not always proceeded smoothly. The history of vaccine research and development has important implications for today, as a variety of factors threaten to fragment this network.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630981     DOI: 10.1203/01.PDR.0000106317.36875.6A

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  4 in total

1.  Maternal level of awareness and predictors of willingness to vaccinate children against COVID 19; A multi-center study.

Authors:  Awoere T Chinawa; Josephat M Chinawa; Edmund N Ossai; Nduagubam Obinna; Vivian Onukwuli; Ann E Aronu; Chuka P Manyike
Journal:  Hum Vaccin Immunother       Date:  2021-10-06       Impact factor: 4.526

2.  Immunogenicity of a whole-cell pertussis vaccine with low lipopolysaccharide content in infants.

Authors:  Tatiane Queiroz Zorzeto; Hisako Gondo Higashi; Marcos Tadeu Nolasco da Silva; Emilia de Faria Carniel; Waldely Oliveira Dias; Vanessa Domingues Ramalho; Taís Nitsch Mazzola; Simone Corte Batista Souza Lima; André Moreno Morcillo; Marco Antonio Stephano; Maria Angela Reis de Góes Antonio; Maria de Lurdes Zanolli; Isaias Raw; Maria Marluce dos Santos Vilela
Journal:  Clin Vaccine Immunol       Date:  2009-03-04

Review 3.  HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design.

Authors:  Mattia Bonsignori; S Munir Alam; Hua-Xin Liao; Laurent Verkoczy; Georgia D Tomaras; Barton F Haynes; M Anthony Moody
Journal:  Trends Microbiol       Date:  2012-09-13       Impact factor: 17.079

Review 4.  The Delay in the Licensing of Protozoal Vaccines: A Comparative History.

Authors:  Clarisa Beatriz Palatnik-de-Sousa; Dirlei Nico
Journal:  Front Immunol       Date:  2020-03-06       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.